Alcobra Priced, Nasdaq: ADHD
Israeli drug company developing a non-stimulant ADHD treatment.
Industry: Health Care
First Day Return: -5.6%
Industry: Health Care
ADHD
Israeli drug company developing a non-stimulant ADHD treatment.
| IPO Data | |
|---|---|
| IPO File Date | 01/14/2013 |
| Offer Price | $8.00 |
| Price Range $10.00 - $12.00 | |
| Offer Shares (mm) | 3.1 |
| Deal Size ($mm) | $25 |
| Lock-Up Date | IPO Pro Only |
| Street Research | IPO Pro Only |
| IPO Data | |
|---|---|
| IPO Date | 05/21/2013 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $25 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | Tel Aviv, Israel |
| Founded | 2008 |
| Employees at IPO | 3 |
| Website www.alcobra-pharma.com | |
IPO News for Alcobra
Alcobra (ADHD) Performance
